Methylprednisolone and Nucynta drug interactions - from FDA reports

Summary

Drug interactions are reported only by a few people who take Methylprednisolone and Nucynta together. This review analyzes the effectiveness and drug interactions between Methylprednisolone and Nucynta. It is created by eHealthMe based on reports of 4 people who take the same drugs from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on methylprednisolone and tapentadol hydrochloride (the active ingredients of Methylprednisolone and Nucynta, respectively), and Methylprednisolone and Nucynta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. (latest outcomes from Methylprednisolone 24,054 users)

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. (latest outcomes from Nucynta 29,161 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

4 people who take Methylprednisolone, Nucynta are studied.


Number of reports submitted per year:

Methylprednisolone and Nucynta drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Full blood count decreased
  4. Injury
  5. Nausea (feeling of having an urge to vomit)
  6. Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye)
  7. Panic attack
  8. Pemphigoid (tense blisters on the skin)
  9. Pruritus (severe itching of the skin)
  10. Pulmonary embolism (blockage of the main artery of the lung)

Most common drug interactions by gender *:

female:
  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Emotional distress
  5. Fear
  6. Injury
  7. Panic attack
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Quality of life decreased
male:
  1. Bone density decreased
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Weight increased
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Dizziness
  8. Full blood count decreased
  9. Nausea (feeling of having an urge to vomit)
  10. Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

40-49:
  1. Dizziness
  2. Emotional distress
  3. Fear
  4. Injury
  5. Nausea (feeling of having an urge to vomit)
  6. Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye)
  7. Pemphigoid (tense blisters on the skin)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Quality of life decreased
  10. Weight increased
50-59:

n/a

60+:
  1. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  2. Dehydration (dryness resulting from the removal of water)
  3. Diarrhoea
  4. Full blood count decreased
  5. Pruritus (severe itching of the skin)
  6. Thrombosis (formation of a blood clot inside a blood vessel)

* Approximation only. Some reports may have incomplete information.


Do you take Methylprednisolone and Nucynta?

You are not alone:




Related publications that referenced our studies

Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Methylprednisolone and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Nucynta and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Methylprednisolone and Nucynta
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Methylprednisolone and Nucynta (7,252 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.